Earnings and Growth Analysis : Timber Pharmaceuticals (NASDAQ:TMBR)

0
140

Earnings results for Timber Pharmaceuticals (NASDAQ:TMBR)

Timber Pharmaceuticals, Inc. is estimated to report earnings on 09/21/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-2.64.

Analyst Opinion on Timber Pharmaceuticals (NASDAQ:TMBR)

Dividend Strength: Timber Pharmaceuticals (NASDAQ:TMBR)

Timber Pharmaceuticals does not currently pay a dividend. Timber Pharmaceuticals does not have a long track record of dividend growth.

Insiders buying/selling: Timber Pharmaceuticals (NASDAQ:TMBR)

In the past three months, Timber Pharmaceuticals insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $138,444.00 in company stock.

Earnings and Valuation of Timber Pharmaceuticals (NASDAQ:TMBR

More latest stories: here